iShares Biotechnology ETF (IBB) Covered Calls
The iShares Biotechnology ETF is a passively managed fund providing broad exposure to U.S.-listed companies in the biotechnology and pharmaceutical sectors. By tracking the ICE Biotechnology Index, the fund offers a diversified vehicle for capturing growth in therapeutic research, gene therapy, and drug development. It is a highly liquid instrument, frequently used by investors seeking to express a thematic view on medical innovation while balancing the risks inherent in this sector.
You can sell covered calls on iShares Biotechnology ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IBB (prices last updated Fri 4:16 PM ET):
| iShares Biotechnology ETF (IBB) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 165.51 | -0.72 | 161.97 | 166.26 | 1.9M | - | 11 |
| Covered Calls For iShares Biotechnology ETF (IBB) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 165 | 2.35 | 163.91 | 0.7% | 31.9% | |
| Apr 17 | 166 | 4.70 | 161.56 | 2.7% | 27.4% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Core Business and Products
This exchange-traded fund serves as a benchmark for the biotechnology industry. It holds a basket of companies engaged in the development, manufacture, and commercialization of therapeutic treatments. Unlike more speculative or narrowly focused funds, IBB is anchored by large-cap "biotech giants" with established balance sheets and revenue streams, which helps mitigate the extreme volatility often seen in smaller-cap clinical-stage firms. The fund is a primary tool for investors who want to participate in the long-term potential of the healthcare sector’s most innovative segment.
Competitive Landscape
IBB operates in a space with several highly liquid, optionable competitors. Its most direct comparison is the SPDR S&P Biotech ETF, which follows an equal-weighted approach and thus offers a different risk profile. Other significant, optionable alternatives include the First Trust NYSE Arca Biotechnology Index Fund and the VanEck Biotech ETF. Investors typically choose between these based on their preference for market-cap weighting versus equal-weighting and their specific interest in small-cap versus large-cap exposure.
Strategic Outlook and Innovation
The strategic utility of this fund is centered on capturing breakthroughs in medical science and the steady acquisition cycle of the broader pharmaceutical industry. While biotechnology is sensitive to regulatory changes and interest rate environments—which impact the cost of capital for R&D—the sector remains a vital defensive and growth component for long-term investors. IBB acts as an evergreen instrument for tactical asset allocation, providing a transparent and efficient way to maintain exposure to the future of healthcare innovation across various market cycles.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PL covered calls | |
| 3. | SPY covered calls | 8. | IWM covered calls | 3. | RCAT covered calls | |
| 4. | EEM covered calls | 9. | FXI covered calls | 4. | AXTI covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | LUNR covered calls | |
Want more examples? IAU Covered Calls | IBCP Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
